The Barcelona Clinic Liver Cancer (BCLC) updated its recommendations for the prognosis and treatment of liver cancer, with a strong emphasis on personalizing treatment decisions.
“There have been major advances in the armamentarium for hepatocellular carcinoma (HCC) since the last official update of the Barcelona Clinic Liver Cancer (BCLC) prognosis and treatment strategy published in 2018,” wrote lead author Maria Reig, MD, PhD, the head of the hepatic oncology unit (BCLC Group) at